INTRODUCTION
Mono-ADP-ribosylation is a post-translational covalent modification which transfers the ADP-ribose moiety of NAD+ to a cellular protein. It is a reversible process, and both synthetic enzymes, the mono-ADP-ribosyltransferases (EC 2.4.2.31) [1] , and degrading enzymes, the mono-ADP-ribosylhydrolases (EC 3.2.2.14) [2] , have been characterized. The mono-ADPribosyltransferases are localized in the nucleus [3] , plasma membrane [4] , cytosol [1, 5] and mitochondria [6] . These enzymes are specific for the bond formed between the amino acid and the ADP-ribose group. Arginine- [1, 5] , cysteine- [7] and diphthamide- [8] specific ADP-ribosyltransferases exist. The ADP-ribosylhydrolases seem to be localized in the soluble fractions of cell homogenates [9, 10] . Like the transferases, these enzymes are also specific for the bond between the amino acid and ADPribose [11, 12] .
ADP-ribosylations are involved in the regulation of protein function. For example, in the photosynthetic bacterium Rhodospirillum rubrum a nitrogenase is inactivated by ADPribosylation and restored to its original activity when the ADPribose group is removed by an ADP-ribosylhydrolase (for review see [13] ). Recent work from several laboratories has shown that nitric oxide, possibly independently of cyclic GMP, stimulates ADP-ribosylation of proteins in several different tissues and organisms [14] [15] [16] [17] . Various G proteins have been shown to be modified by endogenous ADP-ribosylation, and this alters their activity [18-2 1] . In many other cases, though, the exact nature of the acceptors or how the ADP-ribosylation reaction itself is regulated is not known (e.g. [22] [23] [24] ).
Previous results from this laboratory and others have demonstrated changes in ADP-ribosylation with development or differentiation. Results from this laboratory have previously protein and enzyme activity were very low in heart preparations from 1-15-day-old animals. Thereafter the ADP-ribosylation and enzyme activity increased gradually to adulthood. Bacillus cereus phosphatidylinositol-specific phospholipase C, known to hydrolyse glycosylphosphatidylinositol anchors of proteins, released the mono-ADP-ribosyltransferase from membrane preparations of both rat and quail in a dose-dependent, Zn2+_ inhibited manner. Thus it appears that a membrane-bound form of arginine-specific mono-ADP-ribosyltransferase is present in heart membranes from a variety of species and is not speciesspecific. The activity of this ADP-ribosyltransferase appears to be developmentally regulated and to be bound to the cardiac membranes by a glycosylphosphatidylinositol anchor.
demonstrated the presence of a 52 kDa ADP-ribosylation product which is modified at an arginine residue in the adult rat heart plasma membrane; however, in 1-day-old rat heart this product was not detected [24] . In many species, such as the rat and mouse, the heart is relatively immature at birth, while in other species, including the quail, the heart is much more mature at birth or hatching. It is possible that the difference in ADP-ribosylation of the 52 kDa protein in the 1-day-old versus the adult rat is due to developmental changes in the heart. There are also developmental changes in ADP-ribosylation in other organs [25] [26] [27] .
Several other authors have also demonstrated the presence of a mono-ADP-ribosyltransferase activity or an ADP-ribosylation product in the mammalian heart. The ADP-ribosylation of a 39 kDa protein in the rat heart cytosol increases when heart is treated with sodium nitroprusside [14] . In rabbit ventricles [28] and canine cardiac sarcolemma [29] , the ADP-ribosylation of a protein component ofthe adenylate cyclase complex is implicated in the stimulation of adenylate cyclase activity. ADPr;.bosyltransferase activity has been detected in canine sarcoplasmic reticulum and sarcolemma at low levels [29] .
The aim of the present study was to further investigate the developmental aspect of the ADP-ribosylation reaction and the biochemical and developmental properties of the membranebound arginine-specific ADP-ribosyltransferase in the heart. It was seen that the level of ADP-ribosylation of protein in vitro and the ADP-ribosyltransferase activity increased with increasing development of the rat and mouse heart. ADP-ribosylation of protein and ADP-ribosyltransferase activity were detected in the heart tissue of several animals. Also, the ADP-ribosyltransferase was released from rat and quail cardiac membranes by phosphatidylinositol-specific phospholipase C (PI-PLC), suggesting that it is a glycosylphosphatidylinositol-anchored protein.
Abbreviation used: PI-PLC, phosphatidylinositol-specific phospholipase C. * To whom correspondence should be addressed. 
MATERIALS AND METHODS Subcellular fractionation
The subcellular fractionations were performed as previously described for rat heart [24] with all the tissues used. The F3 membrane fraction, initially identified in [24] , was used in all experiments shown.
ADP-rlbosylation assay
The ADP-ribosylation assay was performed as previously described in the presence of 25 ,ug of F3 membranes, 2 ,uM [a-32P]NAD+ (10 l Ci/nmol) (New England Nuclear, Boston, MA, U.S.A.) [24] and 100 IOM NADP (to inhibit NADase activity).
The mixture was incubated for 30 min at 30 'C. Termination was by addition of SDS sample buffer for SDS/PAGE; 10% gels were used for electrophoresis, as previously described [24] .
ADP-ribosyltransderase and NADase assays
The assay for ADP-ribosyltransferase was performed as described by Moss 30 'C, the assays were terminated by the addition of450 ,u of20 mM Tris/HCl (pH 7.0) or unlabelled 7.5 mM NAD+ in 20 mM Tris/HCl (pH 7.0). The samples were then transferred to 6 cm x 0.8 cm Dowex 1 x 2-400 ion-exchange resin (Sigma) columns. The columns were eluted with 7 ml of 20 mM Tris/HCl (pH 7.0). The last 4 ml contained the ADP-ribosylagmatine and was collected for counting of radioactivity in a scintillation counter.
NADase activities were assayed in the same incubation mixtures as used for the ADP-ribosyltransferase assays. The NADase activity of the incubations was determined by extending the elution from the Dowex 1 x 2 columns. After the 7 ml of Tris/HCl, the columns were further washed with 9 ml of 0.01 M HCI (the last 6 ml of which contained the NAD+) and 8 ml of 0.1 M HCI. The final 7 ml of 0.1 M HCI contained the free ADP-ribose and was collected for counting of radioactivity in a scintillation counter. NADase activity in the rat cardiac membrane preparations was linear with time (0-60 min) and protein concentration (5-30 ,ug Velocities were linear with time (up to 60 min) and with the amount of membrane protein present (between 1 and 40 ,g). The pH optimum was between 7.0 and 7.5 when assayed between pH 6.0 and 9.0.
Developmental changes In the ADP-ribosylatlon of the 52 kDa product and In ADP-rlbosyltransferase activity In the rat heart plasma membrane
To further investigate the age-related difference in cardiac ADPribosylation [24] , cardiac membranes from rats of various ages were subjected to the ADP-ribosylation assay. Figure 1 shows that only very low levels of the 52 kDa ADP-ribosylation product could be detected in cardiac membranes from early neonates. Regression analysis of the data predicted an x-axis intercept at 14.7 days. Thereafter, the level of ADP-ribosylation of the 52 kDa product gradually increased linearly with age. The effect of age on the ADP-ribosyltransferase activity was determined by performing the ADP-ribosyltransferase assay on cardiac plasma membranes from animals of the indicated ages. Figure 2 demonstrates that ADP-ribosyltransferase activity was low in the early neonate and gradually increased linearly thereafter. Regression analysis predicted an x-axis intercept at 8.8 days. The ADP-ribosyltransferase activity at 1 day was less than 5 % of the adult activity.
Cardiac-membrane-bound arginine-specific mono-ADPribosyltransferase activity from various species Subcellular fractions of heart tissue from several species (rat, rabbit, pig, mouse, quail and dog) were obtained. Preliminary E 10 ,o, [24] ) contained mono-ADP-ribosylation products. The in vitro products varied with species, but a 52 kDa product was seen in rat, rabbit, quail and mouse ( Figure 3 ). In quail and mouse another major product of approx. 100 kDa was seen ( Figure 3 ). Dog ( Figure 3 ) and pig (results not shown) did not have any detectable ADP-ribosylation products. Table 1 shows the specific activities of mono-ADPribosyltransferase and NADase in cardiac membrane preparations. The specific activity of the mono-ADPribosyltransferase varied with the species. Cardiac membranes from pig had the lowest activity, dog, rat and rabbit had intermediate activity, mouse had high activity and the quail had the highest activity. Earlier work from this laboratory has shown that inhibition of NADase activity improved the ADPribosylation of the 52 kDa product in rat cardiac membrane preparations [24] . Table 1 shows that, under the assay conditions used rat cardiac membranes had 28 times more NADase activity than mono-ADP-ribosyltransferase activity. All of the other species except quail and mouse had equally high or higher ratios of NADase to ADP-ribosyltransferase activities. The mouse had a lower ratio, but there was still 4.5 times as much NADase activity as ADP-ribosyltransferase activity. The quail cardiac membrane preparation was the exception, where the ratio was less than 1.0.
Because of the abundance of mono-ADP-ribosyltransferase and the relatively low contamination with NADase activity in quail cardiac membranes, the biochemical characteristics of the ADP-ribosyltransferase from this source have been determined. The quail enzyme had an apparent Km value of 470 + 110 1sM, which was similar to that of the rat enzyme. The Vm.aX was 48+12 nmol/min per mg, i.e. over 40 times greater than that seen for the rat enzyme. The initial rate of the reaction was linear with protein concentration (1-10 ,ug) and with time (up to 60 min with either 1 ,ug or 3 ,ug of protein). The pH optimum when assayed between pH 6.0 and 9.5 was broad (7.0-8.5).
Age and developmental differences in activity in other species It was ofinterest to determine whether the developmental changes in protein ADP-ribosylation and mono-ADP-ribosyltransferase activity that have been noted in the rat cardiac membrane preparations also occur in cardiac membrane preparations from other species. For this study, mouse and quail were chosen. The neonate mouse heart had 10-fold less activity than the mouse adult heart (0.35 versus 4.94 nmol/min per mg) while the neonate quail preparation had an activity similar to that of the adult (26.6 versus 31.8 nmol/min per mg). Assays of protein ADPribosylation gave similar results, i.e. assays with neonate mouse heart subcellular fractions did not detect any ADP-ribosylation of protein, while assays with neonate quail heart detected ADPribosylation of the same proteins with the same level of intensity as seen in adult preparations (results not shown).
Release of cardiac-membrane-bound mono-ADP-ribosyltransferase by PI-PLC from Bacillus cereus Work on erythrocyte membrane-associated NADI glycohydrolase (NADase) has shown that the enzyme is released by PI-PLC [31] . This membrane-bound NADase had earlier been speculated to be a mono-ADP-ribosyltransferase [32] . Because of these observations, it was of interest to see what effect treatment of cardiac membranes with PI-PLC would have on mono-ADP- ribosyltransferase and NADase. Therefore rat cardiac membranes were treated with various concentrations of PI-PLC from B. cereus in either the absence or the presence of 100 ,1M ZnSO4, an inhibitor of this bacterial PI-PLC (for review see [33] ). Mono-ADP-ribosyltransferase activity was released in a concentration-dependent, Zn2+-inhibited manner, while the cardiac NADase activity was not (Figure 4 ). Maximum release (approx. 60% of total membrane activity) was caused by concentrations of 0.3 unit/ml and greater of PI-PLC. A concentration of 0.3 unit/ml PI-PLC was thus used for other experiments. Because of the greater abundance of the mono-ADP-ribosyltransferase in the quail cardiac membranes, this tissue was also evaluated for release of the enzyme by PI-PLC. The quail mono-ADP-ribosyltransferase was also released by Pl 
DISCUSSION
The results of this study demonstrate that a developmental increase in the ADP-ribosylation product in heart membranes occurs concomitantly with an increase in ADP-ribosyltransferase activity. In the rat, both 52 kDa product formation and enzyme activity were low to non-detectable in the early neonate, and increased gradually with age. The x-axis intercepts of the regression lines (14.7 days and 8.8 days respectively) suggest that there may be a stable low level of activity for several days after birth before a gradual increase is initiated. The rat heart is not mature at birth and major changes take place post-natally. For example, rat cardiac myocytes divide for several days after birth but DNA replication decreases and is minimal by day 17 [34] .
Thereafter the heart grows mainly by hypertrophy and acquisition of non-muscle cells [34] . The levels of the G proteins [35] [36] [37] , muscarinic receptors [35, 38] and fl-adrenergic receptors [39] are subjected to major changes within the first 17 post-natal days. The parasympathetic and sympathetic innervation to the myocardium develops significantly in the same time frame [40, 41] . In mouse heart, which undergoes post-parturitional maturation similar to the rat, the levels of in vitro protein ADP-ribosylation and ADP-ribosyltransferase activity were again low in preparations from 1-day-old animals compared with adult preparations. In the quail, in which maturation of the heart is much more advanced at hatching, in vitro ADP-ribosylation and ADP-ribosyltransferase activity were equivalent in 1-day-old and adult membrane preparations. It is not clear whether the increase in ADP-ribosylation activity seen in the mouse and rat with age is due to an increase in the amount of enzyme or to a change in some other parameter which allows there to be more enzyme activity (e.g. a change in an inhibitor, activator or posttranslational modification). Other authors also have demonstrated age-dependent differences in ADP-ribosylation. In the rat testis, the guanine nucleotide-dependent mono-ADP-ribosylation of a 20 kDa nuclear protein decreases between 4 and 20 weeks of age [25] . Conversely, in the developing rat liver the NH20H-resistant fraction (NH2OH resistance suggests an arginine linkage of the ADP-ribose) increases almost 40-fold between 1-day-old and adult rat liver [26] . This correlates with an increase in the differentiation and metabolic competence of the rat liver [26] . m-Iodobenzylguanidine, an inhibitor of arginine-specific ADPribosyltransferase, reversibly inhibits proliferation and differentiation of primary chick skeletal myoblast cell cultures [27] . While age-related changes have been noted in the heart and liver, the developmental significance of the differences is not yet understood. Inhibitor studies such as those in the skeletal myoblast cultures suggest that endogenous ADP-ribosylation may be important in the regulation of cellular proliferation and differentiation, and therefore organ development.
The biochemical characterization of the cardiac argininespecific ADP-ribosyltransferase from rat and quail revealed that they had apparent Km values for NADI and pH optima similar to those seen with the skeletal muscle enzyme [4] . The apparent Km values were over ten times higher than those seen for other arginine-specific ADP-ribosyltransferases, such as the one in turkey erythrocyte cytosol [42] . This biochemical similarity to the membrane-bound skeletal muscle form and dissimilarity to other forms agrees with the recent observation of Zolkiewska et al. [43] that cDNA prepared from skeletal muscle ADPribosyltransferase RNA hybridized to cardiac RNA but not to RNA from several other tissues. Both observations suggest that skeletal muscle and cardiac muscle arginine-specific ADPribosyltransferases are similar if not identical proteins, while the predominant ADP-ribosyltransferases in other tissues are less similar.
The similarities of the skeletal muscle and cardiac argininespecific ADP-ribosyltransferase have been extended even further. Zolkiewska et al. [43] predicted that the skeletal muscle enzyme has two potential sites for glycosylphosphatidylinositol posttranslational modification. The cardiac enzyme from both rat and quail was released by treatment with bacterial PI-PLC in a dose-dependent and Zn2+-inhibited manner. The release was specific, as another enzyme, NADase, was not released. These observations are also suggestive of a glycosylphosphatidylinositol-anchored protein [33] .
The levels of enzyme activity and in vitro ADP-ribosylation detected varied greatly with the species of animal from which the heart was obtained. All species tested, though, contained detectable ADP-ribosyltransferase activity in cardiac membranes. This observation suggests that the enzyme is involved in a reaction which is common to all hearts and is not species-specific.
An observation which may point to a need for caution in interpreting studies on the ADP-ribosylation of endogenous protein was that, while all tissues tested contained ADPribosyltransferase activity (Table 1) , not all showed detectable ADP-ribosylation of protein (Figure 3 ). This could be due to the conditions of the ADP-ribosylation assay. For example, 2 ,uM NADI is probably limiting for studies of tissues with high NADase and/or high ADP-ribosyltransferase activities such as the pig and quail.
In conclusion, this study has further examined the capacity of cardiac membranes to ADP-ribosylate protein by studying ADPribosylation patterns and arginine-specific membrane-bound ADP-ribosyltransferase. It is seen that the protein ADPribosylation and enzyme activity increase with post-parturitional development in at least two species (rat and mouse). The enzyme activity was detected in all cardiac membranes tested but varied in specific activity to a large extent with the species studied. Cardiacmembrane-bound ADP-ribosyltransferase was released from membranes by PI-PLC, while cardiac membrane-bound NADase was not. This is consistent with the ADP-ribosyltransferase being anchored to membranes by glycosylphosphatidylinositol.
